| Autor: |
Reavis ZW; Department of Pharmacology & Cancer Biology, School of Medicine, Duke University, Durham, NC, USA.; College of Medicine, University of Central Florida, Orlando, FL, USA., Mirjankar N; Ixcela, The Internal Fitness™ Company, Bedford, MA, USA., Sarangi S; Ixcela, The Internal Fitness™ Company, Bedford, MA, USA., Boyle SH; Department of Psychiatry & Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA., Kuhn CM; Department of Pharmacology & Cancer Biology, School of Medicine, Duke University, Durham, NC, USA., Matson WR; Ixcela, The Internal Fitness™ Company, Bedford, MA, USA., Babyak MA; Department of Psychiatry & Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA., Matson SA; Ixcela, The Internal Fitness™ Company, Bedford, MA, USA., Siegler IC; Department of Psychiatry & Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA., Kaddurah-Daouk R; Department of Psychiatry & Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA., Suarez EC; Department of Psychiatry & Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA., Williams RB; Department of Psychiatry & Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA., Grichnik K; American Anesthesiology, Sunrise, FL, USA., Stafford-Smith M; Department of Anesthesiology, School of Medicine, Duke University, Durham, NC, USA., Georgiades A; Department of Psychiatry & Behavioral Sciences, School of Medicine, Duke University, Box 3454 DUMC, Durham, NC, 27710, USA. anastasia.georgiades@duke.edu. |
